TYPTF (Entropy Neurodynamics) Other Stockholders Equity: $0.00 Mil (As of Dec. 2025)


What is Entropy Neurodynamics Other Stockholders Equity?

Entropy Neurodynamics TYPTF -45.63% Other Stockholders Equity is $0.00 Mil as of Dec. 2025. The stock has 5 warning signs investors should review.

Entropy Neurodynamics's Other Stockholders Equity for the quarter that ended in Dec. 2025 was $0.00 Mil.

Entropy Neurodynamics's quarterly Other Stockholders Equity declined from Dec. 2024 ($-0.00 Mil) to Jun. 2025 ($-0.00 Mil) but then increased from Jun. 2025 ($-0.00 Mil) to Dec. 2025 ($0.00 Mil).

Entropy Neurodynamics's annual Other Stockholders Equity declined from Jun. 2022 ($0.00 Mil) to Jun. 2023 ($0.00 Mil) and declined from Jun. 2023 ($0.00 Mil) to Jun. 2025 ($-0.00 Mil).

Entropy Neurodynamics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Entropy Neurodynamics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Entropy Neurodynamics Other Stockholders Equity Chart

Entropy Neurodynamics Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun25
Other Stockholders Equity
Get a 7-Day Free Trial -0.00 0.00 0.00 0.00 -0.00

Entropy Neurodynamics Semi-Annual Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 0.00

Entropy Neurodynamics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Entropy Neurodynamics (TYPTF) has a Other Stockholders Equity of $0.00 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Entropy Neurodynamics and its competitors.
Is Entropy Neurodynamics' Other Stockholders Equity too high?
Entropy Neurodynamics' current Other Stockholders Equity is $0.00 Mil.
How does Entropy Neurodynamics' Other Stockholders Equity compare to VRTX and REGN?
Entropy Neurodynamics' Other Stockholders Equity of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Entropy Neurodynamics and its competitors. Entropy Neurodynamics's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entropy Neurodynamics stock overvalued right now?
Based on GuruFocus' analysis, Entropy Neurodynamics (TYPTF) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 12% above its estimated fair value. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Entropy Neurodynamics (TYPTF), the current Other Stockholders Equity is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Entropy Neurodynamics Business Description

Other Exchanges ENP:Australia
Address 117 Camberwell Road,, Hawthorn East, Suite 1.01, Camberwell, Melbourne, VIC, AUS, 3123
Entropy Neurodynamics Ltd is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. The company's lead program is TRP-8803. TRP-8803 is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) with potential to alleviate numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe.